SipNose

SipNose Develops an Innovative Nasal Drug Delivery Device for Local, Systemic, and Central Nervous System IndicationsSipNose has developed an innovative nasal drug delivery device for local, systemic, and central nervous system indications. The company’s flexible solutions are suitable for clinical or home use, daily or emergency administration, and for pediatric, adult, and elderly patients. The company's device allows for novel treatments of a variety of neurological conditions.Founded in 2011, SipNose collaborates with global pharmaceutical and biopharmaceutical companies. Its headquarters is located in Yokneam Illit, Israel.